## 

|||||Page|
|---|---|---|---|---|
|Reference and Administrative|||Details ofthe Charity, its Trustees and Advisers||
|Trustees' Report||||2-7|
|Independent|Auditors'|Report|on the Financial Statements|8-11|
|Consolidated|Statement|of Financial Activities||12|
|Consolidated|Balance Sheet|||13|
|Charity Balance Sheet||||14|
|Consolidated|Statement|of Cash Flows||15|
|Notes to the|Financial Statements|||16-31|





## 

|Trustees||Mr G L Adroit (Resigned 31 October 2023)|Mr G L Adroit (Resigned 31 October 2023)|Mr G L Adroit (Resigned 31 October 2023)|Mr G L Adroit (Resigned 31 October 2023)|Mr G L Adroit (Resigned 31 October 2023)|Mr G L Adroit (Resigned 31 October 2023)|
|---|---|---|---|---|---|---|---|
|||Mrs J Berry||||||
|||Mr M K Evans, Vice|||President|(Appointed|4 May 2023)|
|||Mrs P Eyles (Resigned 5 February 2023)||||||
|||Mrs J M Hearne,||Vice President||||
|||Mrs L Hookings,||Vice President||||
|||Mr M A Hookings||||||
|||Mrs B Lawton||||||
|||Mrs L McCaig||||||
|||Mrs C M Piper,|Vice||President|||
|||Miss P A Roberts, President||||||
|||Mr D Rogers, Vice President||||||
|||Mr R Tuttle, Former|||Chair|||
|||Mrs K N Westaway,|||Chair|||
|||Mr P F V White,||Vice President/Honorary|||Secretary|
|||Mr M H Tucker,|Vice||Chair|||
|Charity registered||||||||
|number||200905||||||
|Principal office||Highlyn||||||
|||6 Haldon Close||||||
|||Torquay||||||
|||Devon||||||
|||TQ12NA||||||
|Independent|auditors|Bishop Fleming|LLP|||||
|||Chartered<br>Accountants||||||
|||Statutory<br>Auditors||||||
|||2nd Floor Stratus||House||||
|||Emperor Way||||||
|||Exeter Business||Park||||
|||Exeter||||||
|||EX13QS||||||
|Solicitors||Wollens||||||
|||Carlton House||||||
|||30The Terrace||||||
|||Torquay||||||
|||Devon||||||
|||TQ1 1BS||||||





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

||||Restricted|Unrestricted|Total|Total|
|---|---|---|---|---|---|---|
||||funds|funds|funds|funds|
|||Note|2023|2023<br>E|2023|2022f|
|Income from:|||||||
|Donations,<br>grants and legacies||||236,999|236,999|430,920|
|Other trading<br>activities||||14,687|14,687|2,480|
|Investments||||80,540|80,540|26,088|
|Total income||||332,226|332,226|459,488|
|Expenditure<br>on:|||||||
|Raising funds||||778|778||
|Charitable<br>activities|||15,864|1,368,013|1,383,877|78,046|
|Total expenditure|||15,864|1,368,791|1,3&4,655|78,046|
|Net movement<br>in|funds||(15,864)|(1,036,565)|(1,052,429)|381,442|
|Reconciliation<br>of|funds:||||||
|Total funds brought|forward||49,920|3,284,596|3,334,516|2,953,074|
|Net movement<br>in funds|||(15,864)|(1,036,565)|(1,052,429)|381,442|
|Total funds carried forward|||34,056|2,248,031|2,282,087|3,334,516|





## 

## 

|||||2023||2022|
|---|---|---|---|---|---|---|
|||Note|||||
|Fixed assets|||||||
|Tangible assets||10||1,528|||
|||||1,528|||
|Current assets|||||||
|Debtors||12|28,052||119,663||
|investments||13|355,000||1,286,696||
|Cash at bank and|in hand||1,907,892||1,938,117||
||||2,290,944||3,344,476||
|Creditors: amounts|falling due within one||||||
|year||14|(10,385)||(9,960)||
|Net current assets||||2,280,559||3,334,516|
|Total assets less|current liabilities|||2,282,087||3,334,516|
|Total net assets||||2,282,087||3,334,516|
|Charity funds|||||||
|Restricted funds:|||||||
|Restricted funds||15|34,056||49,920||
|Total restricted<br>funds||15||34,056||49,920|
|Unrestricted<br>funds|||||||
|Designated<br>funds||15|1,429,230||2,180,036||
|General funds||15|818,801||1,104,560||
|Total unrestricted|funds|15||2,248,031||3,284,596|
|Total funds||||2,282,087||3,334,516|



## 



## 

## 




## 

||||2023|2022|
|---|---|---|---|---|
||||E||
|Cash flows from operating|activities||||
|Net cash used<br>in operating|activities||(1,040,551)|398,006|
|Cash flows from investing|activities||||
|Interests<br>from investments|||80,540|26,088|
|Purchase<br>of tangible fixed assets|||(1,910)||
|Proceeds from sale of investments|||931,696||
|Net cash provided<br>by investing<br>activities|||1,010,326|26,088|
|Cash flows from financing|activities||||
|Net cash provided<br>by financing<br>activities|||||
|Change<br>in cash and cash|equivalents<br>in|the year|(30,225)|424,094|
|Cash and cash equivalents|at the beginning|ofthe year|1,938,117|1,514,023|
|Cash and cash equivalents|at the end of|the year|1,907,892|1,938,117|
|The notes on pages 16to 31 form part ofthese financial statements|||||





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

|||Restricted|Unrestricted|Total|Total|
|---|---|---|---|---|---|
|||funds|funds|funds|funds|
|||2023|2023|2023|2022|
|||E|||F|
|Donations|and grants||68,156|68,156|67,507|
|Legacies|||166,033|186,033|360,437|
|Gift aid|||2,810|2,810|2,976|
||||236,999|236,999|430,920|
|TOTAL 2022||1,000|429,920|430,920||



## 

||||Unrestricted|Total|Total|
|---|---|---|---|---|---|
||||funds|funds|funds|
||||2023f|2023|2022|
|Events committee|||1,122|1,122||
|Linen League sales|||210|210||
|Torquay|Girls Grammar|School|855|855|287|
|Pennies|for Plastic||178|178||
|Raffles and fayres|||385|385|1,212|
|Bed push|||1,051|1,051||
||||3,801|3,801|1,534|
|TOTAL 2022|||1,534|1,534||





## 

## 

## 

## 

|||Unrestricted|Total|Total|
|---|---|---|---|---|
|||funds|funds|funds|
|||2023f|2023<br>E|2022|
|Sales||10,886|10,886|946|
|TOTAL 2022||946|946||
|Investment|income||||
|||Unrestricted|Total|Total|
|||funds|funds|funds|
|||2023|2023|2022|
|Investment|income|80,540|80,640|26,088|
|TOTAL 2022||26,088|26,088||



## 

## 

||||Support|Total|Total|
|---|---|---|---|---|---|
|||Direct costs|costs|funds|funcls|
|||2023|2023|2023|2022|
|||F|||E|
|Gifts to hospital||1,344,100||1,344,100|48,796|
|Other charitable|activities||39,777|39,777|29,250|
|||1,344,100|39,777|1,383,877|78,046|
|TOTAL 2022||48,796|29,250|78,046||



## 



## 

## 

## 

## 

||||Total|Total|
|---|---|---|---|---|
||||funds|funds|
|||2023|2023|2022|
||||E||
|Office costs||4,940|4,940|6,125|
|Depreciation||382|382||
|Sundry expenses||11,121|11,121|93|
|Bank charges||2,314|2,314|3,244|
|Legal and professional|fees|l6,020|16,020|12,288|
|Honoraria||5,000|5,000|7,500|
|||39,777|39,777|29,250|
|TOTAL 2022||29,250|29,250||





## 

## 

## 

||||Restricted|Unrestricted|Total|Total|
|---|---|---|---|---|---|---|
||||funds|funds|funds|funds|
||||2023<br>f|2023<br>f|2023<br>K|2022f|
|Radiotherapy<br>scanner|||15,323|574,677|590,000||
|AMU equipment||||408,992|408,992||
|Computers<br>on wheels||||86,330|86,330||
|Ultrasound<br>equipment||||77,501|77,501||
|Chairs||||49,029|49,029||
|Phlebotomy<br>equipment||||39,245|39,245||
|Dementia<br>equipment||||33,263|33,263||
|Ventilator<br>equipment||||16,975|16,976||
|Virtual<br>Reality headsets||||9,850|9„850||
|Mobil interactive<br>table||||7,115|7,116||
|Bladder scanner||||7,114|7,114||
|HiLow beds||||6,300|6,300||
|Xion Endoflex system||||3,051|3,051||
|Chart trollies and theatre stools||||||24,451|
|Concealment<br>trollies||||||6,568|
|FES||||||6,254|
|Portable videolarygngoscopes||||||3,246|
|Theatre poles/chairs||||||3,176|
|Other smaller grants||||8,794|9,336|5,101|
||||15,864|1,328,236|1,344,100|48,796|
|Total 2022|||14,477|41,819|56,296||
|Auditors'<br>remuneration|||||||
||||||2023|2022|
|Fees payable<br>to the charity's|auditor||for the audit ofthe charity's|annual|||
|accounts|||||8,775|8,350|
|Fees payable to the chanty's|auditor||in respect of:||||
|All non-audit<br>services not induded||above|||2,352|2,188|





## 

## 

|Tangible fixed assets||
|---|---|
|GROUP||
||Fixtures and|
||fittings|
|COST OR VALUATION||
|At 1 January 2023|30,027|
|Additions|1,910|
|Disposals|(21,917)|
|At 31 December 2023|10,020|
|DEPRECIATION||
|At 1 January 2023|30,027|
|Charge for the year|3&2|
|On disposals|(21,917)|
|At 31 December 2023|8,492|
|NET BOOK VALUE||
|At 31 December 2023|1,528|
|At 31 December 2022||





## 

## 

## 

## 

||Fixtures and|
|---|---|
||fittings|
|COST OR VALUATION||
|At 1 January 2023|30,027|
|Additions|1,910|
|Disposals|(21,917)|
|At 31 December 2023|10,020|
|DEPRECIATION||
|At 1 January 2023|30,027|
|Charge for the year|382|
|On disposals|(21,917)|
|At 31 December 2023|8,492|
|NET BOOK VALUE||
|At 31 December 2023|1,528|
|At 31 December 2022||



## 

## 

||Group|Group|Charity|Charity|
|---|---|---|---|---|
||2023|2022|2023|2022|
||E||||
|DUE WITHIN ONE YEAR|||||
|Prepayments|777|783|777|783|
|Legacies receivable|27,275|118,880|27,275|118,880|
||28,052|119,663|28,052|119,663|





## 

## 

## 

||||Group<br>2023f|Group<br>2022f|Charity<br>2023f|Charity<br>2022|
|---|---|---|---|---|---|---|
|Unlisted|investments|(liquid)|355,000|1,286,696|355,000|1,286,696|



## 

||||Group|Group|Charity|Charity|
|---|---|---|---|---|---|---|
||||2023f|2022<br>f|2023<br>f|2022|
|Amounts|owed to group undertakings|||||85,474|
|Accruals|and deferred|income|10,385|9,960|10,385|9,960|
||||10,385|9,960|10,385|95,434|





## 

## 

|||||||Balance at|
|---|---|---|---|---|---|---|
|||Balance at 1||||31|
|||January|||Transfers|December|
|||2023|Income|Expenditure<br>E|In/out|2023f|
|UNRESTRICTED FUNDS|||||||
|DESIGNATED FUNDS|||||||
|Equipment<br>commitments||2,180,036||(1,324,745)|573,939|1,429,230|
|GENERAL FUNDS|||||||
|General Funds - all funds||1,104,560|332,226|(44,046)|(573,939)|818,801|
|TOTAL UNRESTRICTED|||||||
|FUNDS||3,284,596|332,226|(1,368,791)||2,248,031|
|RESTRICTED FUNDS|||||||
|Cardiac unit||5,719||||5,719|
|Radiotherapy<br>unit||15,323||(15,323)|||
|Diabetic and Asthmatic|patients|22,480||||22,480|
|Neurology<br>department||2,347||||2,347|
|Heart machines||149||(149)|||
|EAU 3||500||||500|
|Endoscopy||2,010||||2,010|
|Cardiology||392||(392)|||
|The Eye Clinic||1,000||||1,000|
|||49,920||(15,864)||34,056|
|TOTAL OF FUNDS||3,334,516|332,226|(1,384,655)||2,2&2,087|





## 

## 



## 

## 

## 

## 

|||||||Balance at|
|---|---|---|---|---|---|---|
|||Balance at||||31|
|||1 January|||Transfers|December|
|||2022|Income|Expenditure|in/out|2022|
|||E|E||||
|UNRESTRICTED FUNDS|||||||
|DESIGNATED FUNDS|||||||
|Equipment<br>commitments||1,500,337||(4,393)|684,092|2,180,036|
|GENERAL FUNDS|||||||
|General Funds||1,389,340|458,488|(59,176)|(684,092)|1,104,560|
|TOTAL UNRESTRICTED|||||||
|FUNDS||2,889,677|458,488|(63,569)||3,284,596|
|RESTRICTED FUNDS|||||||
|Cardiac unit||5,719||||5,719|
|Radiotherapy<br>unit||15,323||||15,323|
|Diabetic and Asthmatic|patients|22,480||||22,480|
|Neurology<br>department||2,347||||2,347|
|Heart machines||250||(101)||149|
|Patient and visitor care||12,376||(12,376)|||
|EAU 3||500||||500|
|Endoscopy||2,010||||2,010|
|Hospital Wards||2,000||(2,000)|||
|Cardiology||392||||392|
|The Eye Clinic|||1,000|||1,000|
|||63,397|1,000|(14,477)||49,920|
|TOTAL OF FUNDS||2,953,074|459,488|(78,046)||3,334,516|





## 

## 

|Analysis|of n|et assets between funds -curr|ent year|||
|---|---|---|---|---|---|
||||Restricted|Unrestricted|Total|
||||funds|funds|funds|
||||2023|2023|2023|
|Tangible|fixed|assets||1,528|1,528|
|Current|assets||34,056|2,256,888|2,290,944|
|Creditors|due|within one year||(10,385)|(10,385)|
|TOTAL|||34,056|2,248,031|2,282,087|



## 

|Analysis|ofn|et ass|ets|between funds -prior|year|||
|---|---|---|---|---|---|---|---|
||||||Restricted|Unrestricted|Total|
||||||funds|funds|funds|
||||||2022|2022|2022|
||||||F|||
|Current|assets||||49,920|3,294,556|3,344,476|
|Creditors|due|within|one|year||(9,960)|(9,960)|
|TOTAL|||||49,920|3,284,596|3,334,516|



## 

|||||||||||Group|Group|
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||2023f|2022|
|Net<br>income/expenditure||for|the|year|(as|per|Statement|of|Financial|||
|Activities)||||||||||(1,052,429)|381,442|
|ADJUSTMENTS FOR:||||||||||||
|Depreciation|charges|||||||||382||
|Dividends,<br>interests<br>and||rents|from|investments||||||(80,540)|(26,088)|
|Decrease<br>in|debtors|||||||||91,611|43,025|
|increase<br>in|creditors|||||||||425|481|
|NET CASH|PROVIDED|BY/(USED||IN) OPERATING ACTIVITIES||||||(1,040,551)|398,860|





## 

## 

||Group|Group|
|---|---|---|
||2023|2022|
||E||
|Cash in hand|1,907,892|1,938,117|
|TOTAL CASH AND CASH EQUIVALENTS|1,907,892|1,938,117|



## 

|||At 1||At 31|
|---|---|---|---|---|
|||January||December|
|||2023|Cash flows|2023|
|||f.|||
|Cash|at bank and in hand|1,938,117|(30,225)|1,907,892|
|Liquid|investments|1,286,696|(931,696)|355,000|
|||3,224,813|(961,921)|2,262,892|



## 

